29th Harvard Annual Update Neurology 2021

This program provides a comprehensive, evidence-based review of state-of-the-art practices for outpatient and inpatient neurology. Education covers the latest guidelines, clinical strategies, and recent advances, including the use of genetic tests, optimal use of imaging, new approaches for diagnosis, and expanded options for treatment for a wide array of neurological diseases.

Education is practical and focused on patient outcomes. Led by the foremost authorities in neurology subspecialties, the program provides tools to improve your care of patients with common, complex, and rare neurological conditions. As updates are presented, they are paired with specific practice recommendations to help you optimize patient care and outcomes.

As updates are presented, they are paired with specific practice recommendations to help you incorporate them into practice for improved patient care and outcomes. This includes:

• The new guidelines for epilepsy, stroke, neuromuscular disorders
• COVID-19 and stroke
• Management of neurological complications of checkpoint inhibition and other immunotherapies
• Comprehensive updates for treatment of neurologic pain
• Expert instruction for neuro-ophthalmology
• Expanded options to diagnose and treat dementia
• Improved management of headache
• Best practices for treatment of neurologic autoimmune disorders
• Steps to ensure delivery of high-quality care in the emergency room and in outpatient settings
• Techniques to effectively manage epilepsy and psychogenic non-epileptic seizures
• Best practices in neuro-oncology
• New insights and best practices for myelopathy and other spinal cord disorders
• Expanded options to treat movement disorders
• Updates in neuroinfectious disease
• State-of-the-art approaches to concussion and coma
• Expanded options to diagnose and treat cerebellar ataxias
• Alcohol and the nervous system: what we now know
• Optimal use of imaging

Topics/Speakers :
– 1. Monday, October 11, 2021
– Advances in Our Understanding of Hyperkinetic Movements – Edison K Miyawaki, MD
– Best Practices for Imaging in Neurologic Diseases – Joshua P Klein, MD, PhD
– Functional Neurocircuitry of Cognition and Cognitive Syndromes – Kirk R Daffner, MD
– Instructive Video Cases in Parkinsonism and Hypokinetic Movement Disorders – Abby L Olsen, MD, PhD
– Introduction – Sashank Prasad, MD and Martin A Samuels, MD
– Non-Pharmacologic Therapy of Movement Disorders – Michael T Hayes, MD
– Q_A Advances in Our Understanding of Hyperkinetic Movements – Edison K Miyawaki, MD
– Q_A Best Practices for Imaging in Neurologic Diseases – Joshua P Klein, MD, PhD
– Q_A Functional Neurocircuitry of Cognition and Cognitive Syndromes – Kirk R Daffner, MD
– Q_A Instructive Video Cases in Parkinsonism and Hypokinetic Movement Disorders – Abby L Olsen, MD, PhD
– Q_A Non-Pharmacologic Therapy of Movement Disorders – Michael T Hayes, MD
– Q_A State-of-the Art Approaches to the Diagnosis of Dementia – Scott M McGinnis, MD
– Q_A State-of-the-Art Approaches in the Treatment of Dementia – Gad A Marshall, MD
– Q_A Updates in the Practical Management of Parkinsonism – Jordan Paulson, MD
– Q_A with Course Directors – Tracey A Milligan, MD and Martin A Samuels, MD
– State-of-the Art Approaches to the Diagnosis of Dementia – Scott M McGinnis, MD
– State-of-the-Art Approaches in the Treatment of Dementia – Gad A Marshall, MD
– Updates in the Practical Management of Parkinsonism – Jordan Paulson, MD
– 2. Tuesday, October 12, 2021
– Brain Tumors in 2021 State-of-the-Art and Emerging Treatment Options – Tracy Batchelor, MD
– Cases in Geriatric Neurology – David M Pilgrim, MD
– Current Approaches to Myopathy Cases – Anthony A Amato, MD
– Day 2 Introduction
– Neurologic Emergencies Quick Identification and Steps to Take to Optimize Patient Outcomes – Saef Izzy, MD
– Neuropathy and Neuromuscular Junction Cases Offering Clinical Pearls – Christopher T Doughty, MD
– Q_A Brain Tumors in 2021 State-of-the-Art and Emerging Treatment Options – Tracy Batchelor, MD
– Q_A Cases in Geriatric Neurology – David M Pilgrim, MD
– Q_A Neuropathy and Neuromuscular Junction Cases Offering Clinical Pearls – Christopher T Doughty, MD
– Q_A State-of-the-Art Approaches to Stroke Prevention and Treatment – Galen V Henderson, MD
– Q_A Updates in Genetics and Stroke – Christopher D Anderson, MD
– Q_A Visual Disturbances – Sashank Prasad, MD
– State-of-the-Art Approaches to Stroke Prevention and Treatment – Galen V Henderson, MD
– Updates in Genetics and Stroke – Christopher D Anderson, MD
– Visual Disturbances – Sashank Prasad, MD
– 3. Wednesday, October 13, 2021
– Below-the-Belt Neurology – Tamara B Kaplan, MD
– Best Practices for Psychogenic Non-Epileptic Seizures – Barbara A Dworetzky, MD
– Day 3 Introduction
– KEYNOTE—State-of-the-Art Treatment of ALS – Merit E Cudkowicz, MD
– Meet the Expert Problematic Epilepsy Cases in Pregnancy – P Emma Voinescu, MD
– Neurogenetics and Impact on Clinical Practice – Scott Plotkin, MD
– New Concepts in Non-Pharmacologic Treatment of Epilepsy – Ellen J Bubrick, MD
– Q_A Below-the-Belt Neurology – Tamara B Kaplan, MD
– Q_A Best Practices for Psychogenic Non-Epileptic Seizures – Barbara A Dworetzky, MD
– Q_A KEYNOTE—State-of-the-Art Treatment of ALS – Merit E Cudkowicz, MD
– Q_A Meet the Expert Problematic Epilepsy Cases in Pregnancy – P Emma Voinescu, MD
– Q_A Neurogenetics and Impact on Clinical Practice – Scott Plotkin, MD
– Q_A New Concepts in Non-Pharmacologic Treatment of Epilepsy – Ellen J Bubrick, MD
– Q_A State-of-the-Art Differential Diagnosis of Epilepsy Video Cases – Tracey A Milligan, MD
– Q_A Updates in Pharmacological Treatment of Epilepsy – Jong Woo Lee, MD, PhD
– State-of-the-Art Differential Diagnosis of Epilepsy Video Cases – Tracey A Milligan, MD
– Updates in Pharmacological Treatment of Epilepsy – Jong Woo Lee, MD, PhD
– 4. Thursday, October 14, 2021
– Cerebellar Ataxias – Claudio Melo De Gusmao, MD
– Day 4 Introduction
– Expanded Options for Treating Eye Movement Disorders – Robert M Mallery, MD
– Neurological Complications of Checkpoint Inhibition and Other Immunotherapies in Cancer Patients – Jorg Dietrich, MD
– Optimizing Your Approach to Treating Multiple Sclerosis – Maria Houtchens, MD
– Q_A Cerebellar Ataxias – Claudio Melo De Gusmao, MD
– Q_A Expanded Options for Treating Eye Movement Disorders – Robert M Mallery, MD
– Q_A Neurological Complications of Checkpoint Inhibition and Other Immunotherapies in Cancer Patients – Jorg Dietrich, MD
– Q_A Optimizing Your Approach to Treating Multiple Sclerosis – Maria Houtchens, MD
– Q_A State-of-the-Art Differential Diagnosis of Multiple Sclerosis – Kristin Galetta, MD
– Q_A The Neurology of Alcohol – Michael E Charness, MD
– Q_A Treating Neurological Cancer – Eudocia Quant Lee, MD, MPH
– Q_A Updates in Alzheimer_s Disease – Dennis J Selkoe, MD
– State-of-the-Art Differential Diagnosis of Multiple Sclerosis – Kristin Galetta, MD
– The Neurology of Alcohol – Michael E Charness, MD
– Treating Neurological Cancer – Eudocia Quant Lee, MD, MPH
– Updates in Alzheimer_s Disease – Dennis J Selkoe, MD
– 5. Friday, October 15, 2021
Closing Remarks – Course Directors
Concussion Guidance to Improve Patient Outcomes – William J Mullally, MD
Diagnosing Unusual and Difficult Cases of Headache – Angeliki Vgontzas, MD
How to Deliver the Best Care for Neck and Back Pain – Shamik Bhattacharyya, MD
Issues in Women_s Neurology – Mary Angela O_Neal, MD
KEYNOTE—How Neurologists Think What My Errors Taught Me – Martin A Samuels, MD
Q_A Concussion Guidance to Improve Patient Outcomes – William J Mullally, MD
Q_A Diagnosing Unusual and Difficult Cases of Headache – Angeliki Vgontzas, MD
Q_A How to Deliver the Best Care for Neck and Back Pain – Shamik Bhattacharyya, MD
Q_A Issues in Women_s Neurology – Mary Angela O_Neal, MD
Q_A KEYNOTE—How Neurologists Think What My Errors Taught Me – Martin A Samuels, MD
Q_A Updates in the Neurologic Impact of COVID-19 – Shibani Murkej, MD
Q_A Updates in What Anesthesiologists Can Now Provide – Martin A Samuels, MD (In reaplcement for Christopher Gilligan, MD)
Q_A Use of Integrative Therapies in the Treatment of Headache – Carolyn Bernstein, MD
The New Options for Treating Chronic Migraine – Rebecca Burch, MD
Updates in the Neurologic Impact of COVID-19 – Shibani Murkej, MD
Updates in What Anesthesiologists Can Now Provide – Christopher Gilligan, MD
Use of Integrative Therapies in the Treatment of Headache – Carolyn Bernstein, MD

Release Date : MONDAY, OCTOBER 11, 2021 – FRIDAY, OCTOBER 15, 2021